Compare HYFM & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HYFM | HKPD |
|---|---|---|
| Founded | 1977 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2M | 10.6M |
| IPO Year | 2020 | 2025 |
| Metric | HYFM | HKPD |
|---|---|---|
| Price | $1.98 | $0.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 97.1K | 74.5K |
| Earning Date | 11-12-2025 | 08-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,443,000.00 | $20,313,818.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $37.86 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $1.50 | $0.68 |
| 52 Week High | $7.50 | $3.79 |
| Indicator | HYFM | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 47.39 | 24.41 |
| Support Level | $1.51 | $0.68 |
| Resistance Level | $2.74 | $0.74 |
| Average True Range (ATR) | 0.31 | 0.05 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 32.11 | 7.25 |
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.